Item 5.07 Submission of Matters to a Vote of Security Holders.



The following are the voting results on each matter submitted to the
stockholders of CVS Health Corporation (the "Company") at the Annual Meeting of
Stockholders held on May 11, 2022 (the "Annual Meeting"). The proposals below
are described in detail in the proxy statement filed by the Company on April 1,
2022 (the "Proxy Statement"). There were present at the Annual Meeting, in
person or by valid proxy, the holders of 1,139,788,473 shares of the Company's
common stock, constituting a quorum.

At the Annual Meeting, 11 nominees for director were elected to the Company's
Board of Directors for a term of one year (Item 1). The Company proposal
regarding the ratification of the appointment of Ernst & Young LLP as the
Company's independent registered public accounting firm for 2022 (Item 2) was
approved. The Company proposal to approve, on an advisory basis, the
compensation of the Company's named executive officers as disclosed in the Proxy
Statement (Item 3) was approved. Five stockholder proposals (Items 4, 5, 6, 7,
and 8) were not approved.


Item                                                                    For               Against            Abstained        Broker Non-Votes
1.      The election, for one-year terms, of persons
        nominated for election as directors of the
        Company, as set forth in the Company's Proxy
        Statement, was approved by the following votes:
        Fernando Aguirre                                     980,147,086           4,942,589            2,361,204          152,337,594
        C. David Brown II                                    921,004,907          64,110,649            2,335,323          152,337,594
        Alecia A. DeCoudreaux                                981,033,116           4,151,581            2,266,182          152,337,594
        Nancy-Ann M. DeParle                                 972,420,338          12,943,153            2,087,388          152,337,594
        Roger N. Farah                                       969,456,061          15,758,278            2,236,540          152,337,594
        Anne M. Finucane                                     961,929,331          23,425,711            2,095,837          152,337,594
        Edward J. Ludwig                                     974,606,439          10,568,872            2,275,568          152,337,594
        Karen S. Lynch                                       978,273,848           7,721,357            1,455,674          152,337,594
        Jean-Pierre Millon                                   953,549,562          31,648,123            2,253,194          152,337,594
        Mary L. Schapiro                                     981,394,995           3,978,425            2,077,459          152,337,594
        William C. Weldon                                    972,634,619          12,527,031            2,289,229          152,337,594
2.      Company proposal to ratify the appointment of
        Ernst & Young LLP as the Company's independent
        registered public accounting firm for 2022, as
        set forth in the Company's Proxy Statement, was
        approved by the following vote:                    1,116,442,556          20,830,100            2,515,817                         None
3.      Company proposal to approve, on an advisory
        basis, the compensation of the Company's named
        executive officers, as set forth in the
        Company's Proxy Statement, was approved by the
        following vote:                                      903,024,507          80,791,141            3,635,231          152,337,594
4.      Stockholder proposal for reducing the Company's
        ownership threshold to request a special
        stockholder meeting, as set forth in the
        Company's Proxy Statement, was not approved by
        the following vote:                                  417,733,556         566,063,103            3,654,220          152,337,594
5.      Stockholder proposal regarding the Company's
        independent Board Chair, as set forth in the
        Company's Proxy Statement, was not approved by
        the following vote:                                  210,689,771         767,744,358            9,016,750          152,337,594
6.      Stockholder proposal on a civil rights and
        non-discrimination audit focused on
        "non-diverse" employees, as set forth in the
        Company's Proxy Statement, was not approved by
        the following vote:                                   15,848,267         956,586,591           15,016,021          152,337,594
7.      Stockholder proposal requesting paid sick leave
        for all employees, as set forth in the
        Company's Proxy Statement, was not approved by
        the following vote:                                  255,627,021         719,860,486           11,963,372          152,337,594
8.      Stockholder proposal regarding a report on the
        public health costs of the Company's food
        business to diversified portfolios, as set
        forth in the Company's Proxy Statement, was not
        approved by the following vote:                      116,708,035         854,020,238           16,722,606          152,337,594


                                       1

--------------------------------------------------------------------------------

Section 9 - Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits.

(d) Exhibits.

The exhibit to this Current Report on Form 8-K is as follows:

© Edgar Online, source Glimpses